Please provide your email address to receive an email when new articles are posted on . Few adverse events were reported in OPAT containing cefazolin and ceftriaxone. Only 2.7 clinically significant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback